Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
The mechanism of apoptosis has been extensively characterized over the past decade, but little is known about alternative forms of regulated cell death. Although stimulation of the Fas/TNFR receptor family triggers a canonical 'extrinsic' apoptosis pathway, we demonstrated that in the absence of intracellular apoptotic signaling it is capable of activating a common nonapoptotic death pathway, which we term necroptosis. We showed that necroptosis is characterized by necrotic cell death morphology and activation of autophagy. We identified a specific and potent small-molecule inhibitor of necroptosis, necrostatin-1, which blocks a critical step in necroptosis. We demonstrated that necroptosis contributes to delayed mouse ischemic brain injury in vivo through a mechanism distinct from that of apoptosis and offers a new therapeutic target for stroke with an extended window for neuroprotection. Our study identifies a previously undescribed basic cell-death pathway with potentially broad relevance to human pathologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necroptosis is a form of RCD initiated by perturbations of the extracellular or intracellular microenvironment detected by specific death receptors, including (but not limited to) FAS and TNFR1 [423–427], or pathogen recognition receptors (PRRs), including TLR3, TLR4, and Z-DNA binding protein 1 (ZBP1; also known as DAI) [428–430].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
In the citing paper
“Accordingly, chemical inhibitors of RIPK1 including necrostatin-1 (Nec-1) and derivatives (e.g., Nec-1s) robustly inhibit TNFR1-driven necroptosis, in vitro and in vivo [425, 427].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [425]
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Self-citationAutophagy as a Regulated Pathway of Cellular Degradation
Klionsky, D. J., & Emr, S. D. (2000) · Science · doi:10.1126/science.290.5497.1717 · Cited by 3,608 · cited 1×
“Activation of autophagy by necroptotic signaling Autophagy, a large-scale protein degradation and catabolic mechanis”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865 · cited 1×
“4e and data not shown), in autophagy-deficient Atg5 −/− MEF cell”
Self-citationHoller, N., Zaru, R., Micheau, O., Thome, M., Attinger, A., Valitutti, S., Bodmer, J.-L., Schneider, P., Seed, B., & Tschopp, J. (2000) · Nature Immunology · doi:10.1038/82732 · Cited by 1,938
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Self-citationGrowth factor regulation of autophagy and cell survival in the absence of apoptosis
Lum, J. J., Bauer, D. E., Kong, M., Harris, M. H., Li, C., Lindsten, T., & Thompson, C. B. (2005) · Cell · doi:10.1016/j.cell.2004.11.046 · Cited by 1,487
LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394
Self-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“, has been implicated in caspase-independent cell deat”
TUMOR NECROSIS FACTOR RECEPTOR AND Fas SIGNALING MECHANISMS
Wallach, D., Varfolomeev, E. E., Malinin, N. L., Goltsev, Y. V., Kovalenko, A. V., & Boldin, M. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.331 · Cited by 1,312 · cited 10×
“2f), whereas it completely inhibited the appearance of necrotic morphology (nuclear condensation, organelle swelling, early loss of plasma membrane integrity and Nec-1 0 20 40 60 80 100 V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% ) V ia bi lit y (% )…”
InfluentialIntracellular ATP levels determine cell death fate by apoptosis or necrosis.
Eguchi, Y., Shimizu, S., & Tsujimoto, Y. (1997) · PubMed · Cited by 1,243
Cited by
Items 1,001–1,015 of 1,015
Lü, J., Sun, Z., Fang, Y., Zheng, J., Xu, S., Xu, W., Shi, L., Mei, S., Wu, H., Liang, F., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01360 · Cited by 55
“In line with previous experimental results (65), the present study suggested that mitochondrial damage and ROS accumulation after ICH might be caused by necroptosis.”
ResultThe interplay of autophagy and non-apoptotic cell death pathways
(2020) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2019.12.004 · Cited by 50
Brojatsch, J., Lima, H., Palliser, D., Jacobson, L. S., Muehlbauer, S. M., Furtado, R., Goldman, D. L., Lisanti, M. P., & Chandran, K. (2015) · Cell Cycle · doi:10.4161/15384101.2014.991194 · Cited by 50
“Necroptosis, a second form of necrotic cell death, is dependent on RIP-1 signaling.(12,15) We have recently described a third form of necrotic cell death, designated as lysosome-mediated necrosis (LMN), that is characterized by lysosome rupture and broad proteolysis of cytosolic proteins.”
BackgroundKalita, B., Utkin, Y. N., & Mukherjee, A. K. (2022) · Toxins · doi:10.3390/toxins14120839 · Cited by 50
Ben Othmène, Y., Monceaux, K., Belhadef, A., Karoui, A., Ben Salem, I., Boussabbeh, M., Abid-Essefi, S., & Lemaire, C. (2022) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2022.103919 · Cited by 43
Coupienne, I., Fettweis, G., & Piette, J. (2011) · Lasers in Surgery and Medicine · doi:10.1002/lsm.21088 · Cited by 41
“The term necroptosis was introduced in 2005 to refer to this nonapoptotic form of programmed necrotic cell death [14].”
BackgroundWang, Z., Feng, J., Yu, J., & Chen, G. (2019) · Journal of Cell Science · doi:10.1242/jcs.227777 · Cited by 35
“INTRODUCTION Necroptosis is a relatively newly discovered programmed cell death process characterized by necrotic morphology, including the swelling of cellular organelles, rupture of cell membranes and, ultimately, lysis of cells (Degterev et al., 2005; Christofferson and Yuan, 2010; Pasparakis and Vandenabeele, 2015…”
BackgroundEscobar, S. J. D. M., Fong, G. M., Winnischofer, S. M. B., Simone, M., Munoz, L., Dennis, J. M., Rocha, M. E. M., & Witting, P. K. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.022 · Cited by 33
Impact of traumatic brain injury on amyotrophic lateral sclerosis: from bedside to bench
Franz, C. K., Joshi, D., Daley, E. L., Grant, R. A., Dalamagkas, K., Leung, A., Finan, J. D., & Kiskinis, E. (2019) · Journal of Neurophysiology · doi:10.1152/jn.00572.2018 · Cited by 26
“Necroptosis, or programmed necrotic cell death with autophagic induction (Degterev et al. 2005; Vandenabeele et al. 2010), has recently been identified as a major mechanism of cell death in both ALS (Ito et al. 2016; Re et al. 2014) and TBI (Liu et al. 2016; Wang et al. 2012; You et al. 2008).”
BackgroundNeel, D. V., Basu, H., Gunner, G., & Chiu, I. M. (2022) · Immunological Reviews · doi:10.1111/imr.13083 · Cited by 22
Kamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1191815 · Cited by 21
“Such “regulated necrosis” includes necroptosis (19, 20), pyroptosis (94, 95), and ferroptosis (96).”
BackgroundBencze, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010362 · Cited by 20
Rideout, H. J., & Re, D. B. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-49969-7_10 · Cited by 17
Multidimensional profiling in the investigation of small-molecule-induced cell death
Wolpaw, A. J., & Stockwell, B. R. (2014) · Methods in Enzymology · doi:10.1016/b978-0-12-801430-1.00011-1 · Cited by 10
“More recently, small-molecule screens have identified compounds that are essential for defining alternative cell death processes (Degterev et al., 2005; Dixon et al., 2012).”
BackgroundCentofanti, E., Oyler-Yaniv, A., & Oyler-Yaniv, J. (2025) · Molecular Biology of the Cell · doi:10.1091/mbc.e24-10-0438 · Cited by 4
“To induce apoptosis, we treated cells with TNF α , the translation inhibitor cycloheximide (CHX), and a specific inhibitor of RIP1K, Necrostatin-1 (Nec1) (Supplemental Figure S2C) (Degterev et al. , 2005, 2008).”
Metadata
- Authors
- Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- Corresponding author
- Yuan, Junying
- ORCID
- Venue
- Nature Chemical Biology
- Published
- 2005-05-29
- Volume
- 1
- Issue
- 2
- Pages
- 112-119
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2110796758
- Cited by
- 3,068
- References
- 39
- Citations by year
- 2026: 144 · 2025: 217 · 2024: 239 · 2023: 240 · 2022: 237 · 2021: 208 · 2020: 181 · 2019: 150 · 2018: 190 · 2017: 171 · 2016: 161 · 2015: 150 · 2014: 180 · 2013: 126 · 2012: 111
- FWCI
- 15.99
- Type
- journal article
- Language
- en
- Update notices
- addendum (2013-02-15)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Health Assistance Foundation
- National Institute on Aging (R37AG012859)
- National Institute of General Medical Sciences (R01GM064703, R01 GM64703)
- National Institute of Neurological Disorders and Stroke (R01NS037141, R01 NS37141-08)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- necroptosis, non-apoptotic cell death, necrostatin-1, ischemic brain injury, stroke, neuroprotection, autophagy, regulated cell death, small molecule inhibitors
- MeSH terms
- Animals, Brain Ischemia, Humans, Imidazoles, Indoles, Molecular Structure, Signal Transduction, Cell Death, Protein Serine-Threonine Kinases, Cell Line, Tumor, Protein Kinase Inhibitors, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Mice, Receptor-Interacting Protein Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.